Cocrystal Pharma Announces Exclusive Worldwide License and Collaboration Agreement with Merck Pharmaceutical Investing
Xanthic Biopharma Inc. (d.b.a. Green Growth Brands) Announces Name Change to Green Growth Brands Inc. Cannabis Investing News
Hemispherx Biopharma Announces Advancement in Expanded Access Program for Ampligen Pharmaceutical Investing
Windtree Therapeutics to Hold Investor Call Thursday, January 3, 2019 at 8:00 a.m. EST Biotech Investing
BriaCell Announces Switch to Novel Frozen Formulation for Lead Cancer Drug Candidate, Upcoming Attendance at Biotech Showcase™ 2019 and Presentation at Keystone Symposia Conference Biotech Investing
Emergent BioSolutions Announces Submission to FDA of Application Covering Emergency Use Authorization for NuThrax Pharmaceutical Investing
